Dianthus Therapeutics (DNTH) PT Raised to $130 at H.C. Wainwright
Tweet
Share
E-mailGet Alerts DNTH Hot Sheet
Price: $106.20 +2.83%
Rating Summary:
17 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 3 | Down: 5 | New: 34
Rating Summary:
17 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 3 | Down: 5 | New: 34
Join SI Premium – FREE
H.C. Wainwright analyst Swayampakula Ramakanth raised the price target on Dianthus Therapeutics (NASDAQ: DNTH) to $130.00 (from $47.00) while maintaining a Buy rating.
You May Also Be Interested In
- JPMorgan Starts Dianthus Therapeutics (DNTH) at Overweight
- Bank Rakyat Indonesia Persero Tbk PT (BBRI:IJ) (BKRKF) PT Raised to IDR2,860 at Macquarie
- Oracle (ORCL) PT Lowered to $200 at Stifel, Buy Rating Maintained
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
